Impact of the SARS-CoV-2 nucleocapsid 203K/204R mutations on the inflammatory immune response in COVID-19 severity.
Muhammad ShuaibSabir AdroubTobias MourierSara MfarrejHuoming ZhangLuke EsauAfrah AlsomaliFadwa S AlofiAdeel Nazir AhmadAbbas ShamsanAsim KhogeerAnwar M HashemNaif A M AlmontashiriSharif HalaArnab PainPublished in: Genome medicine (2023)
Our data demonstrate an unforeseen connection between nucleocapsid KR mutations and augmented inflammatory immune response in severe COVID-19 patients. These findings provide insights into how mutations in SARS-CoV-2 modulate host immune output and pathogenesis and may contribute to more efficient therapeutics and vaccine development.